Adore Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.40 M
as on 07-07-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 07-07-2024
- Revenue 72.41%
(FY 2022)
- Profit -16.26%
(FY 2022)
- Ebitda 13.88%
(FY 2022)
- Net Worth 41.19%
(FY 2022)
- Total Assets 41.83%
(FY 2022)
About Adore Lifescience
The Corporate was formerly known as Aidlife Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.00 M.
Jatindra Khurana and Dheeraj Singh serve as directors at the Company.
- CIN/LLPIN
U24230HP2012PTC000129
- Company No.
000129
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Adore Lifescience Private Limited offer?
Adore Lifescience Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Antibacterial Drugs, Common Disease Medicines.
Who are the key members and board of directors at Adore Lifescience?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jatindra Khurana | Director | 29-Jan-2022 | Current |
Dheeraj Singh | Director | 30-Apr-2012 | Current |
Financial Performance and Corporate Structure Insights of Adore Lifescience.
Adore Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.41% increase. The company also saw a substantial fall in profitability, with a 16.26% decrease in profit. The company's net worth Soared by an impressive increase of 41.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Adore Lifescience?
In 2019, Adore Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adore Charity & Support Foundation
Active 3 years 8 monthsJatindra Khurana and Dheeraj Singh are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 02 Dec 2022 | ₹2.00 M | Open |
How Many Employees Work at Adore Lifescience?
Unlock and access historical data on people associated with Adore Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adore Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adore Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.